Skip to content

clonal selection

ImmunologyImmune systemHematologic/LymphaticLymphoid organs (lymph nodes, spleen, thymus, bone marrow)

Summary

Clonal selection is the principle of adaptive immunity in which an antigen selectively binds to and activates only those pre-existing lymphocytes (B or T cells) whose receptors are specific for it, driving their proliferation (clonal expansion) and differentiation into effector and memory cells. Each lymphocyte clone carries a unique antigen receptor generated by V(D)J recombination before antigen exposure, which explains specificity, diversity, and immunologic memory.

Detail

**Core concept (Burnet's clonal selection theory):** - Before any antigen exposure, V(D)J recombination (RAG1/RAG2, with TdT adding N-nucleotides) generates a huge repertoire of lymphocytes, each with a single unique antigen receptor (BCR or TCR). - When an antigen enters, only lymphocytes with receptors that bind it with sufficient affinity are "selected" and activated. - Selected cells undergo clonal expansion (proliferation), producing many daughter cells with identical specificity. - Progeny differentiate into effector cells (plasma cells, cytotoxic T cells, helper T cells) and long-lived memory cells.

**Four key tenets:** 1. Each lymphocyte expresses receptors of a single specificity (allelic exclusion ensures one heavy-chain and one light-chain allele is expressed in B cells). 2. Receptor diversity arises randomly and before antigen contact (antigen-independent). 3. Antigen selects and expands specific clones (antigen-dependent). 4. Self-reactive clones are eliminated or silenced during development (central tolerance: negative selection in thymus, clonal deletion and receptor editing in bone marrow; peripheral tolerance: anergy, Tregs).

**B-cell specifics:** - Naive B cells in secondary lymphoid organs bind antigen via surface IgM/IgD, then receive T-helper signals (CD40–CD40L, cytokines) in the germinal center. - In the germinal center: somatic hypermutation (AID enzyme) introduces point mutations in the variable regions, and then *affinity maturation* occurs. B cells with higher-affinity BCRs are preferentially selected (a second round of clonal selection). Class switching (IgM to IgG, IgA, IgE) also occurs via AID and cytokines. - Result: plasma cells secreting high-affinity antibody, plus memory B cells.

**T-cell specifics:** - Naive T cells are selected when their TCR recognizes a peptide on MHC (CD4 with MHC II; CD8 with MHC I) plus costimulation (B7 on APC binding CD28 on T cell, "signal 2"). Without costimulation, anergy results. - IL-2 drives clonal expansion.

**Clinical significance and high-yield associations:** - **Primary vs secondary response:** the primary response has a lag phase and mainly IgM. The secondary response is faster, larger, and mainly IgG with higher affinity, because memory clones are already expanded. This is the basis of vaccination and booster doses. - **Monoclonal vs polyclonal:** a normal response is polyclonal (many clones). Malignancies such as multiple myeloma and Waldenström macroglobulinemia reflect uncontrolled expansion of a single clone (monoclonal spike/M protein on SPEP). Lymphoma and leukemia are clonal expansions as well. Clonality is assessed by light-chain restriction (kappa or lambda only) or by Ig/TCR gene rearrangement studies. - **Autoimmunity:** failure of tolerance mechanisms allows self-reactive clones to survive and expand (e.g., AIRE mutation in APECED/APS-1 causes defective thymic negative selection). - **Immunodeficiency:** RAG mutations lead to SCID or Omenn syndrome because no diverse repertoire is generated. Bruton agammaglobulinemia (BTK) blocks B-cell maturation. - **Immunosuppressants:** drugs such as cyclosporine and tacrolimus (calcineurin inhibitors that block IL-2 transcription), mycophenolate, and azathioprine (purine synthesis inhibitors), basiliximab (anti-CD25), and cyclophosphamide inhibit clonal expansion. Rituximab (anti-CD20) depletes B-cell clones. - **Antigenic drift/shift and immune evasion:** pathogens such as influenza and Trypanosoma (VSG variation) escape previously selected clones. - **Antibiotic resistance and tumor evolution** use the analogous Darwinian concept of selection of pre-existing variants, which can be a conceptual distinction on exams.

**Don't confuse with:** - *Positive/negative selection* (thymic selection of developing T cells), which occurs before antigen-driven clonal selection. - *Affinity maturation* (a refinement of clonal selection within germinal centers). - *Clonal deletion* (the elimination of self-reactive clones, the opposite outcome).

**Quick board pearls:** Specificity and diversity are determined before antigen exposure. Antigen does not instruct the lymphocyte to change its receptor (that was the older instructive theory). One cell = one specificity. Memory cells arise from clonal expansion and underlie vaccine efficacy.

Sources

  • First Aid for the USMLE Step 1 - Immunology: Lymphocyte development, B-cell and T-cell activation
  • Abbas, Lichtman, Pillai. Cellular and Molecular Immunology
  • Robbins & Cotran Pathologic Basis of Disease - Diseases of the Immune System
  • Janeway's Immunobiology
  • Pathoma (Sattar) - Hematopathology and Immunology sections
  • Burnet FM. The Clonal Selection Theory of Acquired Immunity (1959)

Reviewed by Medusa editorial — medical student review. Information here is for study reference only and is not medical advice. Spotted an error? Let us know.